Financial Engines Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Financial Engines Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,922	Closed	-$410K	–	297
2022 Q1	$410K	Sell	8,922 -544	-6%	-$25.9K	﹤0.01%	214
2021 Q4	$580K	Buy	9,466 +5,929	+168%	+$410K	﹤0.01%	147
2021 Q3	$264K	Buy	+3,537	New	+$297K	﹤0.01%	233
2020 Q2	–	Sell	-50,052	Closed	-$1.57M	–	215
2020 Q1	$1.57M	Sell	50,052 -12,217	-20%	-$408K	0.01%	87
2019 Q4	$2.09M	Sell	62,269 -111	-0.2%	-$3.53K	0.01%	77
2019 Q3	$1.84M	Buy	62,380 +154	+0.2%	+$5K	0.01%	74
2019 Q2	$2.15M	Sell	62,226 -2,875	-4%	-$92.2K	0.01%	68
2019 Q1	$2.14M	Sell	65,101 -23,862	-27%	-$705K	0.01%	66
2018 Q4	$2.13M	Buy	+88,963	New	+$2.51M	0.01%	64

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Financial Engines Advisors's ARKG Position: Q2 2022 in Review

Financial Engines Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 8,922 shares — an estimated $410K sold.

Financial Engines Advisors first reported a position in ARKG in Q4 2018 and held it in 9 quarters. The position peaked at $2.15M in Q2 2019. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Financial Engines Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Financial Engines Advisors sold 8,922 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $410K.
Financial Engines Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2018 and held it in 9 quarters.
Financial Engines Advisors's ARK Genomic Revolution ETF position peaked at $2.15M in Q2 2019.
334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Financial Engines Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.